Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
UBE1L causes lung cancer growth suppression by targeting cyclin D1
2008
Chapter 1 Ginsenosides
2008 Standout
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
2004 StandoutNobel
Oxidative Stress and Antioxidant Defense
2012 Standout
Head and neck squamous cell carcinoma
2020 Standout
Signaling pathways in retinoid chemoprevention and treatment of cancer
2004
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Chemoprevention targets for tobacco-related head and neck cancer: Past lessons and future directions
2015
Growth inhibition of cervical cancer cells by the human retinoic acid receptor β gene
2000
Cancer chemoprevention with dietary phytochemicals
2003 Standout
The tor pathway: a target for cancer therapy
2004 Standout
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives
2004 Standout
The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth
2003
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Retinoic Acid Promotes Ubiquitination and Proteolysis of Cyclin D1 during Induced Tumor Cell Differentiation
1999
The molecular biology of head and neck cancer
2010 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Calcium, protease action, and the regulation of the cell cycle
1998
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
Toxicity, metabolism, and impact of mycotoxins on humans and animals
2001 Standout
Lung Cancer Prevention*
2003
Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D
2008
Curcumin: Getting Back to the Roots
2005 Standout
Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2
2002
Nuclear factor-kappa B and cancer: its role in prevention and therapy
2002
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation
2002
Nuclear factor-κB
2004 Standout
Anti‐cancer properties of anthraquinones from rhubarb
2006 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Curcumin: From ancient medicine to current clinical trials
2008 Standout
The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*
1999
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Long‐Term Quality of Life After Total Laryngectomy and Postoperative Radiotherapy Versus Concurrent Chemoradiotherapy for Laryngeal Preservation
2008
Hoxa11 Regulates Stromal Cell Death and Proliferation during Neonatal Uterine Development
2003 StandoutNobel
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
A potential mechanism for fumonisin B1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activity
2000
Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells
2004
Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
2002
Cancer prevention science and practice.
2002
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
GL331 Induces Down-Regulation of Cyclin D1 Expression via Enhanced Proteolysis and Repressed Transcription
2001
GSK-3: tricks of the trade for a multi-tasking kinase
2003 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2017
Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human Health
2011 Standout
Works of Jay Boyle being referenced
Predictors of outcome for advanced‐stage supraglottic laryngeal cancer
2009
Postoperative complications of salvage total laryngectomy
2005
Randomized placebo-controlled trial (RCT) of erlotinib for prevention of oral cancer (EPOC).
2014
Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
1997